0000950170-23-007361 Sample Contracts

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 10th, 2023 • Virax Biolabs Group LTD • In vitro & in vivo diagnostic substances

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 8, 2023, between Virax Biolabs Group Limited, a Cayman Islands exempted company (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

AutoNDA by SimpleDocs
PRE-FUNDED ORDINARY SHARE WARRANT VIRAX BIOLABS GROUP LIMITED
Virax Biolabs Group LTD • March 10th, 2023 • In vitro & in vivo diagnostic substances

THIS PRE-FUNDED WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Virax Biolabs Group Limited, a Cayman Islands exempted company (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 10th, 2023 • Virax Biolabs Group LTD • In vitro & in vivo diagnostic substances • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 8, 2023, between Virax Biolabs Group Limited, a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SERIES B PREFERRED INVESTMENT OPTION VIRAX BIOLABS GROUP LIMITED
Virax Biolabs Group LTD • March 10th, 2023 • In vitro & in vivo diagnostic substances

THIS SERIES B PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Virax Biolabs Group Limited, a Cayman Islands exempted company (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”). The purchase price of one Ordinary Share under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!